Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Ronald E. Myers"'
Autor:
Hee Soon Juon, Marcella Pimpinelli, Brooke Ruane, Charnita Zeigler-Johnson, Russell K. McIntire, Christine S. Shusted, Julie A. Barta, Gregory C. Kane, Nathaniel R. Evans, Ronald E. Myers
Publikováno v:
Clinical Lung Cancer. 22:570-578
One challenge in high-quality lung cancer screening (LCS) is maintaining adherence with annual and short-interval follow-up screens among high-risk individuals who have undergone baseline low-dose CT (LDCT). This study aimed to characterize attitudes
Publikováno v:
Journal of Cancer Education. 37:1099-1107
The Centers for Medicare and Medicaid Services (CMS) supports lung cancer screening (LCS) with annual low-dose computed tomography (LDCT) for patients who undergo shared decision-making (SDM) about LCS. Unfortunately, SDM and LCS rates are low in pri
Autor:
Baskaran Sundaram, Christine S. Shusted, Ronald E. Myers, Gregory C. Kane, Michael Lake, Teresa E. Giamboy, Nathaniel R. Evans, Brooke Ruane, Rickie Brawer, Julie A. Barta
Publikováno v:
Population Health Management
Patient navigation has been proposed to combat cancer disparities in vulnerable populations. Vulnerable populations often have poorer cancer outcomes and lower levels of screening, adherence, and treatment. Navigation has been studied in various canc
Autor:
Anett Petrich, Nicole A Fournakis, Claudine Jurkovitz, Nora Katurakes, Heather Bittner Fagan, Ronald E. Myers, Zugui Zhang
Publikováno v:
Journal of Cancer Education
The national rate of lung cancer screening, approximately 3–5%, is too low and strategies which include shared decision-making and increase screening are needed. A feasibility study in one large primary care practice of telephone-based delivery of
Autor:
Ronald E. Myers, Neha Pancholy, Xiaobing Chen, Zhenchao Zhang, Lifang Hou, Hushan Yang, Theodore N. Tsangaris, Chun Wang, Frederick M. Fellin, Zhaomei Mu, Jinliang Xing, Juan P. Palazzo, Manish Neupane, Daniel P. Silver, Qiang Wei, Rebecca Jaslow, Massimo Cristofanilli, Xiuhong Fu, Max Krall, Inna Chervoneva, Adam C. Berger, Saveri Bhattacharya, Shaogui Wan, Laura Austin, Darayus Toorkey, Maysa M. Abu-Khalaf, Zhong Ye, Xiuling Li, Bingshan Li, Kaelan Yao
Publikováno v:
European Journal of Cancer. 106:133-143
BACKGROUND: Both circulating tumor cell (CTC) and total circulating cell-free DNA (ccfDNA) predict cancer patient prognosis. However, no study has explored the prognostic value of the combined use of CTC and ccfDNA. We aimed to investigate individual
Autor:
Linda Fleisher, Ronald E. Myers, Randa Sifri, Lillian C. Man, Emily Lambert, Melissa DiCarlo, Martha C. Romney
Publikováno v:
Preventive Medicine Reports, Vol 12, Iss, Pp 227-232 (2018)
Preventive Medicine Reports
Preventive Medicine Reports
Although colorectal cancer (CRC) screening in the United States has been increasing, screening rates are not optimal, and there are persistent disparities in CRC screening and mortality, particularly among minority patients. As most CRC screening tak
Autor:
Robert Pilarski, Arthur L. Burnett, Lucia R. Languino, Colette Hyatt, Jacqueline Powers, Robert B. Den, Alberto Briganti, Veda N. Giri, Lorelei A. Mucci, Daniel P. Petrylak, Oliver Sartor, Amie Blanco, Daniel W. Lin, Himisha Beltran, E. David Crawford, Karen E. Knudsen, Mary-Ellen Taplin, Brian T. Helfand, Felix Y. Feng, Costas D. Lallas, E. Michael D. Scott, Wayne H. Pinover, R. Jeffrey Karnes, Scott Weissman, Evan Y. Yu, Timothy R. Rebbeck, Ashley H. Woodson, Matthew J. Schiewer, Todd M. Morgan, William B. Isaacs, Jeffrey N. Weitzel, Alanna Kulchak Rahm, Michael S. Cookson, James A. Eastham, S. Bruce Malkowicz, Neha Vapiwala, Kevin R. Loughlin, Raoul S. Concepcion, Ana Maria Lopez, Jose Moreno, Brock O'Neil, Patrick T. Gomella, Patrick Mille, Charnita Zeigler-Johnson, Howard M. Sandler, Kathleen A. Cooney, William Tester, Sarah M. Nielsen, Thomas J. Polascik, Richard C. Wender, Howard R. Soule, Ronald E. Myers, Scott E. Eggener, Marc B. Garnick, Stacy Loeb, Martin Miner, Anthony J. Costello, Gerald L. Andriole, Amanda E. Toland, David Y.T. Chen, Albert Dobi, Joseph K Izes, Mary B. Daly, Leonard G. Gomella, Mark D. Hurwitz, J. Kellogg Parsons, Matthew L. Freedman, Nathan Handley, Adam P. Dicker, Jianfeng Xu, Michael Russell Mullane, Charles J. Ryan, Edouard J. Trabulsi, Anne Calvaresi, James Ryan Mark, Thenappan Chandrasekar, Colin C. Pritchard, Saud H. AlDubayan, Curtis A. Pettaway, William Kevin Kelly, Lindsey Byrne, Peter R. Carroll, Brittany M. Szymaniak, Alicia K. Morgans, Peter A. Pinto, William L. Dahut, Mark Mann, Ganesh V. Raj, James L. Mohler, Wendy Poage, Heather H. Cheng, Grace L. Lu-Yao
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 24
PURPOSE Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary cancer assessment. Critical needs include optimized multigene testing strategies that incorporate evolving genetic data, consistency in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a0090e4e87cd120ef0899e6263c77c
https://escholarship.org/uc/item/3mg229rb
https://escholarship.org/uc/item/3mg229rb
Autor:
Daniel P. Silver, Weelic Chong, Geetha Jagannathan, Frederick M. Fellin, Kaelan Yao, Terrence P. Cescon, Maysa M. Abu-Khalaf, Chun Wang, Zhaomei Mu, Brian Lu, Manish Neupane, Ana Maria Lopez, Adam C. Berger, Rebecca Jaslow, Massimo Cristofanilli, Saveri Bhattacharya, Ronald E. Myers, Zhenchao Zhang, Qiang Wei, Bingshan Li, Zhong Ye, Theodore N. Tsangaris, Hushan Yang, Lifang Hou, Juan P. Palazzo
Publikováno v:
Breast Cancer Res Treat
PURPOSE: Discordance between HER2 expression in tumor tissue (tHER2) and HER2 status on circulating tumor cells (cHER2) has been reported. It remains largely underexplored whether patients with tHER2(−)/cHER2(+) can benefit from anti-HER2 targeted
Autor:
X. Chen, Xue Zhong, Scott A. Waldman, Chun Wang, Ling Li, James Posey, J. Shu, Hushan Yang, Y. Sun, Bingshan Li, A. Yan, Zhong Ye, Atrayee Basu-Mallick, Bing-Hua Jiang, Ronald E. Myers, Lifang Hou, Danielle Fortuna, Jinliang Xing, Qiang Wei, Juan P. Palazzo
Publikováno v:
Annals of Oncology. 28:2135-2141
Background Distant metastasis accounts for 90% of deaths from colorectal cancer (CRC). Genomic heterogeneity has been reported in various solid malignancies, but remains largely under-explored in metastatic CRC tumors, especially in primary to metast
Autor:
Constantine Daskalakis, Anuragh Gudur, Melissa DiCarlo, Ronald E. Myers, Sally W. Vernon, Sarah E. Hegarty
Publikováno v:
Prev Med
This study investigated predictors of overall and test-specific colorectal cancer screening (CRCS). Stool blood test (SBT) and/or colonoscopy screening were offered to primary care patients in two randomized controlled trials which assessed the impac